141318-80-1

Basic information

• Product Name: S-3,4-Diaminobutyric acid 2HCl
• Synonyms: S-3,4-Diaminobutyric acid 2HCl;(S)-3,4-Diaminobutyric acid dihydrochloride;(S)-3,4-diaminobutanoic acid dihydrochloride;REF DUPL: S-3,4-Diaminobutyric acid 2HCl;(3S)-3,4-diaminobutanoic acid,dihydrochloride
• CAS NO: 141318-80-1
• Molecular Formula: C4H12Cl2N2O2
• Molecular Weight: 191.05628
• Mol File: 141318-80-1.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: S-3,4-Diaminobutyric acid 2HCl(CAS DataBase Reference)
• NIST Chemistry Reference: S-3,4-Diaminobutyric acid 2HCl(141318-80-1)
• EPA Substance Registry System: S-3,4-Diaminobutyric acid 2HCl(141318-80-1)

Safety Data

• Hazardous Substances Data: 141318-80-1(Hazardous Substances Data)

Usage

General Description

S-3,4-Diaminobutyric acid 2HCl is a chemical compound that exists in the form of hydrochloride salt. It is an amino acid derivative that contains two amino groups and a carboxylic acid functional group. S-3,4-Diaminobutyric acid 2HCl has been researched for its potential applications in pharmaceuticals and as a building block in organic synthesis. It has also been studied for its role in various biological processes such as neurotransmission and as a potential drug target. S-3,4-Diaminobutyric acid 2HCl may have potential uses in the development of new drugs and medications, making it of interest to the scientific and medical communities.

InChI:InChI=1/C4H10N2O2.2ClH/c5-2-3(6)1-4(7)8;;/h3H,1-2,5-6H2,(H,7,8);2*1H/t3-;;/m0../s1

Upstream product

• 141291-26-1 (4R)-4-(carbomethoxymethyl)-imidazolidin-2-one 
• 141291-28-3 (4S)-4-(carbo-t-butoxymethyl)-imidazolidin-2-one 

Relevant articles and documents

Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid

R or S aminocarnitine, R or S phosphonium aminocarnitine and R and S 3,4 diaminobutanoic acid, and their derivatives are prepared using starting from aspartic acid with the same configuration as the desired compounds. This process is advantageous from the industrial point of view in terms of the type of reactants used, the reduced volumes of solvents and the possibility of avoiding purification of the intermediate products.

Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid

A process is described for the preparation of R or S aminocarnitine, R or S phosphonium aminocarnitine and R and S 3,4 diaminobutanoic acid, and their derivatives with the following formula: 1where Y is as described in the attached description, starting from aspartic acid with the same configuration as the desired compounds. This process is advantageous from the industrial point of view in terms of the type of reactants used, the reduced volumes of solvents and the possibility of avoiding purification of the intermediate products.

A Practical and Stereoconservative Synthesis of (R)-3-Amino-4-(trimethyl-ammonio)butanoate [(R)-Aminocarnitine], and Its Trimethylphosphonium and Simple Ammonium Analogues Starting from D-Aspartic Acid

We have developed a new stereospecific synthesis of (R)-aminocarnitine using D-aspartic acid as the starting material. This strategy, which is simple and amenable to an industrial scale-up, gives the target compound in six steps and in fairly good overall